KCT0005429尚未招募未知
Human study for investigating the effects Chrysanthemum flower extract on body fat level and related metabolism in obese adults
Ewha Womens University0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 64(Year)（—）
- 性别
- All
入选标准
- •1) Subject who voluntarily agree to participate and signs
- •informed consent form 2) Aged more than 19 years and less than 65 years, women
- •and men 3) Those with waistlines greater than 90 cm for men and 85 cm for women.
- •4) Metabolism score is above 1.332 5) Those who can follow the diet and
- •guidelines during the intervention period
排除标准
- •1) Those who have taken or are likely to take medications
- •that affect body weight, blood sugar, lipids, hypertension, or intestinal health
- •within one month of the first visit : appetite suppressants/accelerators,
- •hormone drugs (female hormones, male hormones, thyroid hormones, steroid drugs,
- •etc.), TCA drugs, laxatives, antidepressants, hypoglycemic agent, Lipidlowering
- •drugs, inflammatory bowel disease drug, diuretics, ß-blocker etc. 2) Those who
- •have taken antibiotics within 2 months of the first visit or are likely to take
- •it during the study 3) Subject diagnosed with the following diseases ? Liver
- •dysfunction or hepatobiliary disease ? Renal dysfunction ? Hyperthyroidism and
- •hypofunction, Cushing's syndrome ? If you have a medical history of severe
- •central nervous system disorders that require hospitalization or medication ?
- •Those with severe cerebrovascular disease, heart disease. However, dizziness If
- •there is no medical history, it may be excluded at the discretion of the
- •researcher. ? Malignant tumor, lung disease, musculoskeletal disease, immune
- •system or inflammatory disease ? A person who complains of gastrointestinal
- •disorders or severe gastrointestinal symptoms such as heartburn, indigestion or
- •severe constipation 4) Those who have experience in surgery such as gastroplasty
- •or enterectomy for weight loss 5) Those who have participated in a commercial
- •obesity program in the past 3 months or have had a calorie-restricted diet
- •treatment 6) Those who have irregular eating habits and lifestyle 7) Those who
- •have difficulty complying with dietary and lifestyle guidelines during the study
- •8) Those who have continuously consumed dietary supplements or herbal medicines
- •affecting their weight, blood sugar, lipids, and hypertension within one month
- •of their first visit. 9) Those who have consistently consumed foods, Probiotics
- •10) Those who have had a weight change of 5% or more within the last 3
- •months 11) Those who have good quality of usual meals (Recommended Food Score
- •> 36) 12) Those who continuously exercises high intensity 13) Those who have
- •hypersensitivity to the test / placebo food or ingredients or have experienced
- •severe food allergic reactions. 14) Participants in other human application
- •research within 1 month of first visit 15) Pregnant or lactating women 16) Those
- •who have difficulty using a smartphone or computer 17) If the researcher deems
- •inappropriate to participate in this study
研究者
相似试验
已完成
不适用
Human study for investigating the effects of chronic intake of Ecklonia cava on body fat level and related metabolism in obese adultsKCT0001074Ewha Womans University80
已完成
不适用
Human study for investigating the effects of chronic intake of a combined extract of grape and omija on body fat level and related metabolism in obese adultsEndocrine, nutritional and metabolic diseaseKCT0001832CJ Cheiljedang78
已完成
不适用
A human study for investigating effects of Acanthopanax koreanum Nakai extract consumption on hepatic function in moderate drinkersDiseases of the digestive systemKCT0001353Jeju Technopark69
已完成
不适用
A human study for evaluation of the effect of Theracurmin CR-033P on improving hepatic function and satety: 12 weeks, multi-center, double-blind, randomized, placebo-controlled trialKCT0002988HANDOK INC90
已完成
1 期
Study on adverse effect and efficacy of a human chemokine derivative in combination with radiotherapy for advanced or metastatic malignancyAdvanced or metastatic malignancyJPRN-UMIN000007681Tokyo Radiation Oncology Clinic20